News


  • Featured
  • All News

24 Sep 2024

Zachary M. Winkler has been named to the Community Legal Services of Philadelphia’s Justice Rising Advocates (“JRA”) Executive Board

Faruqi & Faruqi is proud to share that associate Zachary M. Winkler was recently named to Community Legal Services of Philadelphia's Justice Rising Advocates ("JRA") Executive Board. JRA is a group of young professionals that fight for justice alongside ...

Features: Zachary M. Winkler

Read more

24 Sep 2024

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent FutureFuel Corp. Shareholders in Securities Class Action

On September 18, 2024, United States District Judge Matthew T. Schelp of the Eastern District of Missouri appointed Faruqi & Faruqi, LLP, as sole lead counsel in In re FutureFuel Corp. Securities Litigation, 24-cv-00881-MTS. The suit centers on allegations ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

24 Sep 2024

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Future FinTech Group Shareholders in Securities Class Action

On September 24, 2024, United States Magistrate Judge Jessica S. Allen of the District of New Jersey appointed Faruqi & Faruqi, LLP, as sole lead counsel in Labelle v. Future FinTech Group, Inc. et al., 24-247 (JXN) (JSA). The suit centers on allegations ...

Features: Robert W. Killorin, James M. Wilson, Jr.

Read more

31 Jul 2024

FARUQI & FARUQI SCORES CLASS CERTIFICATION WIN IN FOLGERS COFFEE LITIGATION

On July 31, 2024, Chief Judge Beth Phillips of the Western District of Missouri granted class certification in a false advertising class action against the J.M. Smucker Company and its subsidiary, the Folger Coffee Company. Faruqi & Faruqi, LLP was appointed ...

Read more

10 Jul 2024

Faruqi & Faruqi, LLP, Sole Lead Counsel, Scores Final Approval of $13.95 Million Settlement In In re Peloton Interactive, Inc. Securities Litigation

On July 9, 2024, the Court granted final approval to a $13.95 million settlement in In re Peloton Interactive, Inc. Securities Litigation, No. 21-cv-02369-CBA-PK (E.D.N.Y.). Faruqi & Faruqi, LLP (the "Faruqi Firm") served as sole lead counsel in the action, ...

Read more

17 May 2024

Faruqi & Faruqi Preserves Class Certification Win In Third Circuit

On May 16, 2024, the U.S. Court of Appeals for the Third Circuit declined to grant interlocutory review of the District Court's order granting class certification in Halman Aldubi Provident and Pension Funds Ltd. v. Teva Pharmaceuticals Industries Limited, ...

Read more

26 Apr 2024

Effexor XR direct purchaser settlement information

In re Effexor XR Antitrust Litigation, No. 11-cv-5479 (D.N.J.) You can find the documents relating to the settlement here. ...

Features: Joseph T. Lukens, Peter Kohn

Read more

16 Apr 2024

FARUQI & FARUQI, LLP, PROUD TO ANNOUNCE THAT THE FIRM WAS SELECTED BY CITY OF ATLANTA PENSION PLAN INVESTMENT BOARD TO SERVE AS SECURITIES COUNSEL FOR THE CITY’S THREE PENSION FUNDS

Faruqi & Faruqi is proud to announce that they have been selected by the City of Atlanta Defined Benefit Pension Plan Investment Board to provide securities monitoring and litigation services for the City of Atlanta General Employees' Pension Fund, the ...

Read more

04 Apr 2024

Faruqi & Faruqi, LLP, Sole Lead Counsel, Scores Final Approval of $19.5 Million Settlement In Tahoe Resources, Inc. Securities Litigation

On April 3, 2024, the Court granted final approval to a $19.5 million settlement in In re Tahoe Resources, Inc. Securities Litigation, No. 17-cv-01868-RFB-NJK (D. Nev.). Faruqi & Faruqi, LLP (the "Faruqi Firm") served as sole lead counsel in the action, ...

Read more

27 Mar 2024

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent NewAge Shareholders in Securities Class Action

On March 26, 2024, United States District Judge Daniel D. Domenico of the District of Colorado adopted Magistrate Judge James P. O'Hara's ruling and recommendation to appoint Faruqi & Faruqi, LLP, as sole lead counsel in Clifton v. Willis, et al., 22-cv-03161-DDD-JPO. ...

Features: James M. Wilson, Jr.

Read more

28 Feb 2024

Suboxone $385 Million Settlement Receives Final Court Approval, Faruqi & Faruqi, LLP, Co-Lead Counsel

On February 27, 2024, Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania granted final approval to a $385 million settlement in In re Suboxone Antitrust Litigation, 13-md-02445 (E.D. Pa.). The settlement ...

Read more

22 Dec 2023

Faruqi & Faruqi, LLP Announces Lisa Omoto Promoted to Partner

Faruqi & Faruqi, LLP, is thrilled to announce that Lisa Omoto is promoted to Partner. Lisa focuses her practice on consumer protection litigation. ...

Features: Lisa Omoto

Read more

17 Nov 2023

Faruqi & Faruqi Appointed Sole Lead Counsel to Represent Lordstown Motors, Inc. Shareholders in Securities Class Action

On November 16, 2023, United States District Judge Benita Y. Pearson of the Northern District of Ohio appointed Faruqi & Faruqi, LLP, as sole lead counsel in Lim v. Hightower, et al., 23-cv-1454-BYP. The suit centers on false and misleading statements ...

Features: James M. Wilson, Jr.

Read more

14 Nov 2023

Faruqi & Faruqi Roars!

Faruqi & Faruqi was named a Legal Lion of the Week by Law360 on November 9, 2023 for winning the hotly contested motion for class certification in the Teva Pharmaceuticals securities class action. The Court in the Eastern District of Pennsylvania certified ...

Read more

10 Nov 2023

Faruqi & Faruqi, LLP Certified By the Women’s Business Enterprise National Council

[New York, NY]—November 11, 2023— Faruqi & Faruqi, LLP, a business specializing in legal services, is proud to announce national re-certification as a Women's Business Enterprise by the Women President's Educational Organization - NY, a regional certifying ...

Features: Lubna M. Faruqi

Read more

06 Nov 2023

FARUQI & FARUQI SCORES BIG WIN IN OBTAINING CLASS CERTIFICATION IN SECURITIES ACTION AGAINST TEVA PHARMACEUTICALS INDUSTRIES, LTD.

On November 3, 2023, Judge Karen S. Marston of the District Court for the Eastern District of Pennsylvania granted class certification in a securities action against Teva Pharmaceuticals Industries Limited ("Teva") and certain of its officers and directors, ...

Read more

01 Nov 2023

Suboxone Settlement

On October 30, 2023, the Court overseeing the Suboxone Direct Purchaser Class litigation preliminarily approved a $385 million settlement, reached days before trial was scheduled to begin. Faruqi and Faruqi are co-lead counsel for the Class, in this antitrust ...

Read more

01 Nov 2023

Judge Hellerstein in Novartis $126.85 Anti-Trust Class Action Settlement Approves Distribution of Funds. Faruqi & Faruqi, LLP, serves as Class Counsel.

On October 31, 2023, the Court overseeing the Exforge litigation granted direct purchaser plaintiffs' motion for distribution of the net settlement funds. The Court previously issued an order granting final approval to the $126.85 million settlement between ...

Read more

30 Oct 2023

Faruqi & Faruqi Scores Appellate Win for Consumers in Misleading “Reef Friendly” Sunscreen Case

On October 30, 2023, the Second Circuit Court of Appeals reversed a decision issued by the trial court in Richardson v. Edgewell Personal Care, Case No. 7:21-cv-08275, holding that the "Reef Friendly*" claim on the front-label of Hawaiian Tropic sunscreen ...

Features: Timothy J. Peter, Lisa Omoto

Read more

23 Oct 2023

Faruqi & Faruqi Achieves $385 Million Resolution for Direct Purchasers of Suboxone

New York— Faruqi & Faruqi, LLP announces that as co-lead counsel in the Suboxone Antitrust Litigation, it has achieved a $385 million settlement for a class composed of direct purchasers of Suboxone. The 10-year litigation in the Eastern District of ...

Features: Joseph T. Lukens, Peter Kohn

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania